Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,130.00
Bid: 1,128.00
Ask: 1,132.00
Change: 14.00 (1.25%)
Spread: 4.00 (0.355%)
Open: 1,154.00
High: 1,154.00
Low: 1,124.00
Prev. Close: 1,116.00
CVSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update & Acquisitions

29 Jun 2010 07:00

RNS Number : 3866O
CVS Group plc
29 June 2010
 



 

Trading update and Acquisitions

 

The Board announced on 19 May 2010 that it expected results for the year to be below market expectations. Trading conditions have remained tough throughout the rest of the group's financial year which will end on 30 June 2010. Having reviewed flash numbers the Board now believes that turnover for the year will be in the region of £85m (net of inter company sales of £2m). This is in the region of £1m below Directors' expectations for the final quarter.

 

Whilst the Board is disappointed to report lower than anticipated turnover, the performance will still reflect modest like-for-like growth for the year as a whole (after adjusting for the weather affected months of December 2009 and January 2010) despite the challenging environment.

 

The Board is pleased to report that the Group has delivered a better than expected level of acquisition activity in the year, which is expected to generate annualised turnover in the region of £21 million, compared to the £12m expected at the start of the financial year. However, as previously highlighted, the bulk of these have been acquired in the latter part of the financial year, which means that they will only deliver £6 million of sales in this current year. The total number of surgeries acquired in the year amounted to 41 together with one laboratory.

 

Three new acquisitions have been completed in June funded by internally generated cash, comprising five surgeries located in the vicinity of Mansfield, Horsham and Burgess Hill respectively. The combined annual turnover for the five surgeries is circa £2.7 million.

 

Senior Management Appointment

The Board is also pleased to confirm the recent appointment of Steve Scully as the Director of Practice Operations for the Group. Steve will sit on the Executive Committee and brings with him a broad range of experience and a proven track record in driving growth within large multi site operations.

 

 

For further enquiries please contact:

CVS Group plc

Simon Innes, Chief Executive

Paul Coxon, Finance Director

01379 644 288

 

 

Brewin Dolphin

Richard Jones/Matt Davis

Paul Mason

0845 059 6740

 

 

Buchanan Communications

Richard Oldworth

Ben Romney

020 7466 5000

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTKKFDPKBKBNAB
Date   Source Headline
11th Oct 20164:37 pmRNSHolding(s) in Company
6th Oct 20163:10 pmRNSHolding(s) in Company
5th Oct 20164:26 pmRNSHolding(s) in Company
4th Oct 20163:47 pmRNSHolding(s) in Company
28th Sep 201612:56 pmRNSHolding(s) in Company
23rd Sep 20167:00 amRNSPreliminary Results
22nd Sep 20161:31 pmRNSHolding(s) in Company
16th Sep 20162:43 pmRNSHolding(s) in Company
14th Sep 20165:31 pmRNSHolding(s) in Company
14th Sep 20165:00 pmRNSHolding(s) in Company
12th Sep 20163:52 pmRNSHolding(s) in Company
8th Sep 20165:21 pmRNSHolding(s) in Company
5th Sep 201611:35 amRNSHolding(s) in Company
26th Aug 20165:15 pmRNSHolding(s) in Company
12th Aug 201611:50 amRNSExercise of Options and Total Voting Rights
5th Aug 20162:30 pmRNSHolding(s) in Company
1st Aug 20169:25 amRNSHolding(s) in Company
25th Jul 20167:00 amRNSTrading Update
21st Jul 20169:10 amRNSHolding(s) in Company
15th Jul 20164:10 pmRNSHolding(s) in Company
14th Jul 20163:05 pmRNSExercise of Options and Total Voting Rights
11th Jul 20165:30 pmRNSHolding(s) in Company
7th Jul 20161:35 pmRNSDirector/PDMR Shareholding
6th Jul 20165:15 pmRNSDirector/PDMR and PCA Shareholding
4th Jul 20164:50 pmRNSHolding(s) in Company
28th Jun 201610:55 amRNSBlock Listing Interim Review
27th Jun 201611:00 amRNSExercise of Options and Total Voting Rights
9th Jun 201610:52 amRNSExercise of Options and Total Voting Rights
3rd Jun 20165:20 pmRNSHolding(s) in Company
2nd Jun 20167:00 amRNSHolding(s) in Company
20th May 201610:12 amRNSExercise of Options and Total Voting Rights
13th May 20165:21 pmRNSHolding(s) in Company
22nd Apr 201610:19 amRNSExercise of Options and Total Voting Rights
21st Mar 20164:45 pmRNSExercise of Options and Total Voting Rights
21st Mar 20164:00 pmRNSHolding(s) in Company
21st Mar 20167:00 amRNSInterim Results
25th Feb 20162:48 pmRNSExercise of Options and Total Voting Rights
10th Feb 20166:02 pmRNSHolding(s) in Company
4th Feb 20163:35 pmRNSHolding(s) in Company
3rd Feb 201610:36 amRNSHolding(s) in Company
29th Jan 20166:03 pmRNSHolding(s) in Company
29th Jan 20164:00 pmRNSExercise of Options and Total Voting Rights
19th Jan 20167:00 amRNSNotification of Presentation and Interim Results
18th Jan 20162:39 pmRNSHolding(s) in Company
14th Jan 20165:42 pmRNSHolding(s) in Company
15th Dec 20154:40 pmRNSHolding(s) in Company
14th Dec 20157:00 amRNSBlock Admission
4th Dec 20157:00 amRNSAcquisitions and New Bank Facilities
2nd Dec 20152:01 pmRNSHolding(s) in Company
30th Nov 20156:10 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.